Introducing Slingshot Therapeutics

Slingshot Therapeutics (Slingshot), the Syncona Accelerator, is focused on accumulating and developing a pipeline of early-stage development programmes. Slingshot will efficiently advance and de-risk programmes from academic founders by providing access to high quality management, centralised development expertise, resource, funding and operational support. This centralised structure provides Syncona with a capital efficient and de-risked way to gain more exposure to the returns available from translating highly innovative science into promising biotech assets.